340B Drug Pricing Program
The Supreme Court of the United States today decided to take up AHA’s petition asking to reverse a federal appeals court decision that significantly cuts payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access to care in communities.
We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients.
Amicus Brief Eli Lilly v Cochran Re 340B Contract Pharmacy – Intervention filed June 23, 2021.
Amicus Brief NOVO NORDISK v Cochran Re 340B Contract Pharmacy – Intervention
HRSA will continue enforcement actions against drug manufacturers and contract pharmacy arrangements
Columbus, Ohio-based Mount Carmel Health System goes beyond the walls of its hospital to serve its community and patients through programs such as Street Medicine, which provides free urgent medical care to underinsured or uninsured individuals. Hear from Mount Carmel’s Brian Pierson, vice…
The AHA 340B Advocacy Alliance Wednesday, June 16, at 2:30 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
The 340B program, established by section 340B of the Public Health Service
Act, 42 U.S.C. § 256b, requires as a condition of participating in Medicaid and Medicare Part B that pharmaceutical manufacturers sell outpatient drugs at a discounted price to certain public and not-for-profit hospitals,…
Amy Bricker
President
Express Scripts PBM
1 Express Way
Saint Louis, MO 63121
Dear Ms. Bricker:
The AHA 340B Advocacy Alliance June 16 at 2:30 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program. AHA staff will provide updates on regulatory, legislative and legal actions related to the 340B program.